Saccharomyces cerevisiae fungemia after Saccharomyces boulardii treatment in immunocompromised patients

被引：115

作者：

Riquelme, AJ

Calvo, MA

Guzmán, AM

Depix, MS

García, P

Pérez, C

Arrese, M

Labarca, JA

机构：

[1] Catholic Univ Chile, Sch Med, Clin Microbiol Lab, Santiago, Chile

[2] Catholic Univ Chile, Sch Med, Dept Gastroenterol, Santiago, Chile

[3] Catholic Univ Chile, Sch Med, Dept Internal Med, Santiago, Chile

来源：

JOURNAL OF CLINICAL GASTROENTEROLOGY | 2003年 / 36卷 / 01期

关键词：

Saccharomyces cerevisiae fungemia; Saccharomyces boulardii; immunocompromised patients;

D O I：

10.1097/00004836-200301000-00013

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Saccharomyces boulardii is widely used as a probiotic compound. Clinical data suggest that this agent is safe and effective. We report two cases of fungemia caused by S. cerevisiae occurring in immunosuppressed patients treated orally with S. boulardii. Molecular typing confirmed clonality in isolate strains from patients and the S. boulardii capsule. Physicians caring for immunosuppressed patients must be aware of this potential serious complication of probiotic use.

引用

页码：41 / 43

页数：3

共 29 条

[1] Fungemia with Saccharomyces cerevisiae after treatment with Saccharomyces boulardii [J].